Apex Healthcare

AHEALTH

MYL7090OO003

Pharmaceuticals

End-of-day quote BURSA MALAYSIA Other stock markets 06:00:00 2024-05-09 pm EDT			5-day change	1st Jan Change
3.36 ^MYR	-1.18%		+2.13%	+34.94%

Apr. 15	Apex Healthcare Berhad Proposes the Special Dividend for the Financial Year Ended 31 December 2023	CI
Feb. 22	Apex Healthcare Boosts Dividend Despite Profit Decline in Q4	MT

Apex Healthcare Berhad Appoints Phang Ah Tong as Independent and Non Executive Member of Nomination Committee

May 24, 2018 at 04:59 am EDT

Apex Healthcare Berhad announced that the appointment of Phang Ah Tong as independent and non executive member of nomination committee. The date of changes is May 24, 2018.

Latest news about Apex Healthcare

Apex Healthcare Berhad Proposes the Special Dividend for the Financial Year Ended 31 December 2023	Apr. 15	CI
Apex Healthcare Boosts Dividend Despite Profit Decline in Q4	Feb. 21	MT
Apex Healthcare Berhad Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 21	CI
Apex Healthcare Berhad Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 21	CI
Apex Healthcare Berhad Announces the Final Single-Tier Dividend for the Financial Year Ended December 31, 2023, Payment Date 29 May 2024	Feb. 21	CI
Apex Healthcare Berhad Announces A Special Dividend of the Financial Year Ended 31 December 2023	Feb. 21	CI
Apex Healthcare Berhad Announces Promotion of Miss Chiew Woon Wui from Financial Controller to Chief Financial Officer, Effective on January 1, 2024	Dec. 22	CI
Apex Healthcare Berhad Announces Promotion of Miss Chiew Woon Wui from Financial Controller to Chief Financial Officer, Effective on January 1, 2024	Dec. 22	CI
Apex Healthcare Profit Declines in Q3	Nov. 30	MT
Apex Healthcare Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 29	CI
Apex Healthcare's Profit Shoots Up in Q2	23-08-24	MT
Apex Healthcare Berhad Provides Earnings Guidance for the Year 2023	23-08-23	CI
Apex Healthcare Berhad Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-23	CI
Apex Healthcare Berhad Announces Interim Single-Tier Dividend for the Financial Year Ending 31 December 2023, Payable on 19 September 2023	23-08-23	CI
Apex Healthcare's Profit Climbs in Q1	23-05-25	MT
Apex Healthcare Berhad Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-24	CI
Apex Healthcare Berhad Appoints Yap Seng Chong as Independent and Non-Executive Chairman of Audit Committee, Date of Change 18 May 2023	23-05-17	CI
Apex Healthcare Berhad Appoints Yap Seng Chong as Independent and Non Executive Member of Risk Committee, Effective Form May 18, 2023	23-05-17	CI
Apex Healthcare Berhad Appoints Datuk Noharuddin Bin Nordin @ Harun as Independent and Non Executive Member of Remuneration Committee, Date of Change May 18, 2023	23-05-17	CI
Apex Healthcare Berhad Appoints Leong Khai Cheong as Independent and Non Executive Member of Nomination Committee, Effective Form May 18, 2023	23-05-17	CI
Apex Healthcare Berhad Approves the Special Dividend for the Financial Year Ended 31 December 2022	23-05-17	CI
Apex Healthcare Berhad Approves the Final Single-Tier Dividend for the Financial Year Ended December 31, 2022	23-05-17	CI
Apex Healthcare Berhad Appoints Yap Seng Chong as Independent and Non-Executive Director, Effective from May 18, 2023	23-05-17	CI
Apex Healthcare Berhad Announces the Cessation of Datuk Noharuddin Bin Nordin @ Harun as Independent and Non Executive Member of Risk Committee	23-05-17	CI
Apex Healthcare Berhad Announces the Retirement of Jackson Chevalier Yap-Kit-Siong, as Member of Remuneration Committee	23-05-17	CI

Apex Healthcare Berhad is a Malaysia-based healthcare company. The Company is focused on the development, manufacturing, wholesaling, marketing and distribution of pharmaceuticals, consumer healthcare products, and medical devices. It operates through three segments: Manufacturing, Distribution and Corporate. It is engaged in the manufacturing of pharmaceutical products. It is involved in the distribution of pharmaceutical and healthcare products. The Corporate segment comprises investments, properties and others. It is also engaged in the contract manufacturing of orthopedic devices. Its brands include XEPATM, AVO, AGNESIA, AEVA and HENNSON, and products bearing these brands are sold in approximately 16 territories worldwide. The Company's distribution channels reach hospitals, clinics, independent and chain pharmacies, supermarkets and health stores, enabling products to reach customers, namely doctors, pharmacists, nutritionists, retailers, and ultimately the patients or consumers.

Sector

Pharmaceuticals

Calendar

2024-05-14 - Ex-dividend day for extraordinary dividend

More about the company

Income Statement Evolution

More financial data

Ratings for Apex Healthcare

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

3.36 MYR

Average target price

2.644 MYR

Spread / Average Target

-21.31%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
APEX HEALTHCARE	+34.94%	509M
MCKESSON CORPORATION	+20.94%	72.78B
CARDINAL HEALTH, INC.	-1.26%	24.24B
SINOPHARM GROUP CO. LTD.	+8.80%	8.59B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+8.25%	8.38B
HUADONG MEDICINE CO., LTD	-19.42%	8.09B
H. LUNDBECK A/S	+6.35%	4.81B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+16.83%	4.32B
EBOS GROUP LIMITED	-1.83%	4.05B
CHINA NATIONAL MEDICINES CORPORATION LTD.	+26.97%	3.79B

Pharmaceuticals Wholesale

Apex Healthcare

Equities

AHEALTH

MYL7090OO003

Pharmaceuticals

Apex Healthcare Berhad Appoints Phang Ah Tong as Independent and Non Executive Member of Nomination Committee

Latest news about Apex Healthcare

Chart Apex Healthcare

Company Profile

Income Statement Evolution

Ratings for Apex Healthcare

Analysts' Consensus

EPS Revisions

Annual profits - Rate of surprise

Sector Pharmaceuticals Wholesale